awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35739362-03E65AC9-9CE2-4261-AC92-CAA002A387EF
Q35739362-03E65AC9-9CE2-4261-AC92-CAA002A387EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35739362-03E65AC9-9CE2-4261-AC92-CAA002A387EF
Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma.
P2860
Q35739362-03E65AC9-9CE2-4261-AC92-CAA002A387EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35739362-03E65AC9-9CE2-4261-AC92-CAA002A387EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53c8f338303decc366bd3f72fa20ae065e2bf60f
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.